The QualityStocks Daily Thursday, August 8th, 2019

Today's Top 3 Investment Newsletters

StockHideout (CAFI) +872.22%

StockMarketWatch (CVRS) +76.86%

Insider Financial (ISBG) +50.00%

The QualityStocks Daily Stock List

PeerStream, Inc. (PEER)

Zacks, OTC Markets, Stockwatch, Proactive Investors, TechCrunch, Wallet Investor, Market Screener, Trading View, 4-Traders, Simply Wall St, MarketWatch, and InvestorsHub reported beforehand on PeerStream, Inc. (PEER), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

PeerStream, Inc. is a communications software innovator listed on the OTC Markets OTCQB. The Company is developing enhanced security and privacy solutions for video, voice, and text applications and data transmission. Employing multi-layered encryption, blockchain technology and other recent innovations, PeerStream is developing its proprietary PeerStream Protocol (PSP) to offer clients maximum data security and confidentiality over distributed or decentralized networks. PeerStream is headquartered in New York, New York.

PeerStream’s offerings target consumer, government, as well as enterprise clients. For 20 years, the Company has built and continues to operate innovative consumer applications. These include Paltalk and Camfrog, two of the largest live video social communities.

PeerStream has also launched its Backchannel product suite in private beta. This includes cross platform applications, middleware and software development kits designed to offer a highly secure end user communication experience when coupled with PSP.

Pertaining to its Consumer Applications, PeerStream’s Paltalk is a top provider of real-time, rich media, interactive social networking applications with more than 200 million registered users globally. The Company’s Camfrog is a cross-platform worldwide video chat community. In addition, its Backchannel is a secure messaging application (app) harnessing blockchain for complete privacy.

Concerning its Business Solutions, PeerStream helps clients identify advantageous distributed technology strategies and integrate public and private blockchain solutions to advance their business goals. The Company is an innovator in blockchain technology.

Regarding its Technology Platform, PeerStream offers a platform for live multimedia streaming and communications, with PeerStream Protocol (PSP). This is an open source peer network for content delivery constructed with blockchain technology.

Recently, PeerStream announced that its partner, YouNow, completed a major milestone: the U.S. Securities and Exchange Commission (SEC) has qualified YouNow’s Reg A+ offering of Props Tokens, YouNow’s utility token for cross-app rewards. This is the first consumer token offering to be qualified under Reg A+.

Alex Harrington, Chief Executive Officer of PeerStream, said, “We’re thrilled that Props received approval for the first consumer token offering under Reg A+. Now that this regulatory approval has been obtained, we are eagerly working towards roll-out within our apps.”

The design of Props Token is to enable a decentralized network of apps, operating independently of one another, to share an underlying currency that rewards end-users who create, consume and also engage with content and services.

PeerStream, Inc. (PEER), closed Thursday's trading session at $3.50, even for the day, on 4 volume with 1 trade. The average volume for the last 3 months is 437 and the stock's 52-week low/high is $2.51999998/$6.00810003.

chart

Aleafia Health, Inc. (ALEAF)

Pot Stock News, SmallCapPower, Stock Gumshoe, Proactive Investors, MicroSmallCap, InvestorsHub, Profit Confidential, New Cannabis Ventures, The Cannabis Investor, Midas Letter, CannabisMarketCap, Stockwatch, InvestorPlace, Wallet Investor, Trading View, technical420, Insider Financial, Stockhouse, and Simply Wall St reported previously on Aleafia Health, Inc. (ALEAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Aleafia Health, Inc. operates as a vertically-integrated cannabis health and wellness company. It has four primary business units: Cannabis Cultivation & Products, Health & Wellness Clinics, Cannabis Education, and Consumer Experience. Aleafia has ecommerce, retail distribution, and provincial supply agreements. The Company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. Aleafia has been named the 2019 top performing company of the year by the TSX Venture Exchange before graduation to the TSX. Aleafia Health is based in Concord, Ontario. The Company lists on the OTC Markets Group’s OTCQX.

Aleafia Health owns three major cannabis product and cultivation facilities. Two are licensed and operational. This includes the first large-scale outdoor cultivation facility in Canada. In addition, Aleafia operates the largest national network of medical cannabis clinics and education centers. These are staffed by MDs, nurse practitioners, as well as educators. Aleafia Health maintains a medical cannabis dataset with more than 10 million data points to inform proprietary illness-specific product development and its highly differentiated education platform FoliEdge Academy.

Aleafia Health has been granted approval by Health Canada for outdoor cannabis cultivation. On June 7, 2019, its wholly-owned subsidiary Aleafia Farms, Inc., was granted a new Standard Cultivation License issued under Health Canada’s Cannabis Regulations at the Company’s Port Perry, Ontario facility. The Licence allows for cannabis cultivation in Zone 1 of Aleafia’s Outdoor Grow facility, with 292,000 sq. ft. of immediate, licensed cultivation area.

Aleafia completed the planting of its first outdoor crop less than one week after securing Health Canada approval for outdoor cultivation. Following the harvest of its first outdoor crop, the dried flower will be transported to the Company’s Paris Facility for extraction and production, adding to its branded product portfolio. The substantial increase in supply will align with the Paris Facility’s Phase II expansion, which increases Aleafia’s extraction capacity to 50,000 kg annually.

Last week, Aleafia Health announced that its wholly-owned subsidiary, Emblem Cannabis Corporation, completed the largest adult-use cannabis order in the Company’s history. The expectation is that the value of the Order will generate proceeds from the sale of cannabis surpassing $1.0 million. It has been shipped to a Canadian Provincial government for distribution to online and retail consumers.

The single Order features all of the Company’s product formats and 17 individual product SKUs (Stock Keeping Units). Aleafia’s average monthly gross revenue generated from the sale of cannabis now consistently and significantly exceeds equivalent revenues produced during the Company’s entire 2018 annual reporting period.

Aleafia Health will announce its 2019 Q2 Financial Results on August 14, 2019 at 7 a.m. EST. Additionally, it will host its Q2 Results Call the same day at 8:30 a.m. EST. The call will be hosted by Chief Executive Officer, Mr. Geoffrey Benic and Chief Financial Officer, Mr. Benjamin Ferdinand.

Aleafia Health, Inc. (ALEAF), closed Thursday's trading session at $0.9075, up 7.1429%, on 359,913 volume with 436 trades. The average volume for the last 3 months is 497,973 and the stock's 52-week low/high is $1.51520001/$5.20499992.

chart

FingerMotion, Inc. (FNGR)

Capital Cube, Stock Target Advisor, Street Insider, Simply Wall St, Wallet Investor, InvestorsHub, OTC Markets, Investors Hangout, Stockwatch, Stockhouse, Real Investment Advice, and Trading View reported earlier on FingerMotion, Inc. (FNGR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FingerMotion, Inc. is a U.S. FinTech (Financial Technology) company with mobile payment and recharge platform operations in the People’s Republic of China (PRC). It is one of five companies in the PRC with access to wholesale rechargeable minutes via top-up credits on the mobile phone. The Company’s vision is to quickly grow its user base through organic means and have this growth develop into an ecosystem of users with high engagement rates using its inventive applications. JiuGe Information Technology is FingerMotion’s wholly-owned Chinese subsidiary. OTCQB-listed, FingerMotion is headquartered in China.

The Company is investing in research and development (R&D). Its primary area of focus is the development of “must have” applications for consumers and businesses. Its longer term focus is to develop a marketing platform capable of leveraging all the meta data collected by the leading telcos into a predictive model that is able to isolate and extract consumer behavior and habits for future monetization.

FingerMotion is developing value added technologies to market to its users. The Company eventually hopes to serve greater than 1 billion users in the China market and eventually expand the model to other regional markets.

Last month, FingerMotion announced that it expanded the breadth of its services with a definitive Portal Sales and Cooperation Agreement with China Unicom, a foremost mobile carrier in China. With the terms of the renewable three-year agreement, China Unicom has migrated the management and developmental control of the portal to FingerMotion's subsidiary, JiuGe Information Technology (JiuGe). The existing platform now handles cellular top up, phone sales, and accessory sales including SIM cards, cases, and prepaid phone cards.

This agreement calls for FingerMotion to share with China Unicom a percentage of the revenues generated from sales on the portal. JiuGe will be responsible for collecting the revenue generated off the platform and paying the costs to maintain the customer service center.

FingerMotion, Inc. (FNGR), closed Thursday's trading session at $3.90, up 11.4286%, on 2,157 volume with 4 trades. The average volume for the last 3 months is 6,929 and the stock's 52-week low/high is $0.370000004/$1.25.

chart

Leagold Mining Corporation (LMCNF)

StreetWise Reports, StockInvest.us, Stockhouse, OTC Markets, Northern Miner, NewstoWatch, Ceo.ca, Metals News, Baystreet, InvestorsHub, and 4-Traders reported previously on Leagold Mining Corporation (LMCNF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Leagold Mining Corporation is a mid-tier gold producer headquartered in Vancouver, British Columbia. The Company focuses on opportunities in Latin America. It formerly went by the name HTI Ventures Corp. It changed its corporate name to Leagold Mining Corporation in August of 2016. Leagold Mining’s shares trade on the OTC Markets Group’s OTCQX.

Leagold Mining owns four operating gold mines in Mexico and Brazil. In addition, the Company has an expansion opportunity in Mexico and a near-term gold mine restart project in Brazil. Leagold has an inventory of 7.1 million ounces of gold reserves from which to grow. Its operating mines are Los Filos, RDM, Fazenda, and Pilar. Its development projects are the Los Filos expansion and Santa Luz.

The expectation is that the Company’s four gold mines in Mexico and Brazil will collectively produce 380,000-420,000 oz gold in 2019 at an All-In Sustaining Cost (AISC) of $920-970/oz. In 2018, Leagold Mining produced 302,550 oz gold – in line with guidance of 295,000- 305,000 oz.

Last week, Leagold Mining reported Q2 and H1 2019 financial and operating results, with consolidated gold production for the six months ended June 30, 2019 of 197,234 oz at AISC of $951/oz sold, resulting in an AISC margin of $65.9 million. Six-month sales of 201,724 oz produced H1 2019 revenue of $258.3 million, earnings from mine operations of $44.2 million, and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $67.3 million.

The Los Filos mine complex expansion preparations were under way in Q2 and started in July. The first task will be the development of an additional vent raise followed by lateral development on key mine infrastructure, extending beyond the 1,330-meter access ramp that was completed in November of 2018. The Company has started a 24,000-meter drill program in the Guadalupe area to convert inferred resources to indicated resources and assess the potential to steepen pit slopes.

Leagold Mining Corporation (LMCNF), closed Thursday's trading session at $1.6601, off by 3.4826%, on 141,465 volume with 144 trades. The average volume for the last 3 months is 86,592 and the stock's 52-week low/high is $0.288599997/$0.446249991.

chart

Orezone Gold Corporation (ORZCF)

Gold Stock Data, Exploration Insights, Macroaxis, TeleTrader, Mining.com, Wallet Investor, Wallmine, Capital Cube, Market Screener, Investing.com, Investors Hangout, Investing News, Investor Place, Stockwatch, Dividend, Investor, InvestorsHub, Street Insider, Northern Miner and Stockhouse reported earlier on Orezone Gold Corporation (ORZCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Orezone Gold Corporation engages in the acquisition, exploration, and development of precious metal properties. The Company’s flagship property is the Bomboré gold project located in Burkina Faso, West Africa. Orezone owns a 90 percent interest in Bomboré, one of the largest undeveloped gold deposits in Burkina Faso. Orezone Gold is headquartered in Vancouver, British Columbia.

Bomboré hosts a large oxide resource underlain by a larger, open sulphide resource. It will be developed in two stages. Development has begun on the project with the first gold pour scheduled for Q2, 2021. Bomboré has first-rate infrastructure with the majority of support facilities in place. This includes camp, offices, as well as warehouse facilities.

Orezone Gold has 12 gold mines in production and 2 in construction. The Company has a proven record of accomplishment of project construction and financing, capital markets and M&A (Mergers & Acquisitions). The Company has simplified the Bomboré gold project and focused on a scale it can finance and build. Bomboré has strong economics. It has an after-tax NPV5% of $361M and IRR (Internal Rate of Return) of 43.8% with a 2.5-year payback.

In 2019, Orezone Gold released an updated Bomboré Sulphide Expansion Feasibility study. Highlights include increasing reserves by 686Koz (+60%). Highlights also include a low AISC of $672 in the first 10 years. Phase 1 construction is well-advanced. It will be completed in Q4 2019.

Recently, Orezone Gold reported the results of its updated feasibility study (the 2019 FS) that incorporates a staged Phase II Sulphide Expansion for its Bomboré Gold Project in Burkina Faso, West Africa.

Mr. Patrick Downey, Orezone Gold President and Chief Executive Officer, said, "The staged development approach at Bomboré results in increased annual gold production, improves operating margins and significantly enhances economics including a material increase in after-tax NPV of $137.5M. The results of the 2019 FS confirm that Bomboré is a long-life, low-cost gold mine and we continue to evaluate additional project opportunities. Equally important, the decision to complete the Phase II Sulphide Expansion after the start-up of oxide operations, allows the Company to fund construction of the sulphide circuit without the need for additional upfront capital."

Orezone Gold Corporation (ORZCF), closed Thursday's trading session at $0.554, up 0.727273%, on 79,127 volume with 11 trades. The average volume for the last 3 months is 33,170 and the stock's 52-week low/high is $0.032000001/$2.5999999.

chart

Park City Group, Inc. (PCYG)

Zacks, Stocks Equity, EarningsCast, Market Screener, AI Stock Finder, Infront Analytics, Investing.com, Stockhouse, TradingView, GlobeNewswire, TMX Money, InvestorsHub, Simply Wall St reported earlier on Park City Group, Inc. (WCVC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Park City Group, Inc. is a Software-as-a-Service (SaaS) provider that brings visibility to the consumer goods supply chain via its wholly-owned ReposiTrak, Inc. subsidiary. ReposiTrak is The Speed Retail Platform, with three product families. These are Compliance & Risk Management, Supply Chain Solutions, and MarketPlace Sourcing and B2B Commerce. The Company mainly serves multi-store retail chains, wholesalers and distributors, and suppliers. Park City Group has its corporate headquarters in Murray, Utah.

For more than 18 years, Park City Group has been helping customers with B2B Vendor Connections, Item & Cost Maintenance, Scan-based Trading, Invoicing from POS or Delivery, Vendor Scorecarding, Reporting & Analytics, Out-Of-Stock & Waste Reporting, and Forecasting & Ordering (Store-level & DC). ReposiTrak was originally co-founded with Leavitt Partners, led by Mr. Michael Leavitt, former Secretary of Health & Human Services, to address the expected rise in regulatory requirements associated with the Food Safety Modernization Act of 2011 (FSMA).

The ReposiTrak platform provides retailers and suppliers with a strong solution suite to help enhance operational control and increase sales. This is while enabling them to protect their brands, lessen risk and remain in compliance with regulatory requirements.

Fundamentally, ReposiTrak is a compliance, supply chain, and e-commerce platform. ReposiTrak partners with retailers, wholesalers, and their suppliers, to boost sales, control risk, and improve supply chain efficiencies. The Company’s platform is the only fully integrated sourcing, compliance, and supplier & item management platform on the market. All of Park City Group’s capabilities are accessible by way of a cloud-based portal that consists of the ReposiTrak Speed Retail Platform.

Recently, ReposiTrak announced that Achatz Handmaid Pie is adopting the ReposiTrak Compliance & Risk Management Solution to automate compliance documentation from its suppliers. Wendy and David Achatz started the namesake pie-making company in their kitchen in Armada Township, Michigan in 1993. Today, Achatz Handmaid Pie is headquartered in Chesterfield, Michigan, where it produces its pies and baked goods.

The Compliance & Risk Management suite deployed by Achatz Handmaid Pie includes food safety and compliance solutions, which are a respected and trusted cornerstone of the ReposiTrak brand. With 85,000 buyer/supplier connections across the platform and endorsements of top trade groups such as FMI, ROFDA and GMDC, ReposiTrak has established itself as the industry standard for a compliance and risk management platform.

Moreover, last month, ReposiTrak announced that Father Sam’s Bakery has adopted the ReposiTrak Compliance & Risk Management Solution to automate compliance with its suppliers. Father Sam’s Bakery (Buffalo, New York) sells pita pocket bread and tortillas for retail, wholesale and food service. The ReposiTrak Speed Retail Platform boosts growth and supports all supply and demand chain activities for retailers, manufacturers, and their trading partners.

Park City Group, Inc. (WCVC), closed Thursday's trading session at $5.09, up 0.992063%, on 18,342 volume with 192 trades. The average volume for the last 3 months is 98,881 and the stock's 52-week low/high is $0.009999999/$0.041000001.

chart

Whitecap Resources, Inc. (SPGYF)

StocksBeat, Wallmine, Investing.com, Wallet Investor, Mining.com, Tech Know Bits, Street Insider, 4-Traders, Dividend Investor, Seeking Alpha and Market Screener reported previously on Whitecap Resources, Inc. (SPGYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Whitecap Resources, Inc. acquires and develops petroleum and natural gas properties in Canada. The Company’s main properties are located in West Central Alberta, Northwest Alberta and British Columbia, Southeast Saskatchewan, West Central Saskatchewan, and Southeast Saskatchewan. Since inception in September 2009, Whitecap has amassed a substantial light oil resource base that provides a strong foundation for continued growth and results on a per share basis. Whitecap Resources has its corporate office in Calgary, Alberta. The Company lists on the OTC Markets.

Whitecap Resources is an oil-weighted growth company. It pays a monthly cash dividend to its shareholders. The Company’s emphasis is on providing sustainable dividends and profitable per share growth enhanced by value added acquisitions.

Whitecap Resources’ portfolio of assets has stable production and low base declines. This provides the Company’s shareholders with a predictable cash flow stream for monthly dividend payments. Moreover, the large resource in place enables Whitecap Resources to grow on a per share basis.

The Company employs a strategy of acquiring sustainable assets with large Discovered Petroleum Initially In Place (DPIIP) and low current recovery factors and moving them through the development chain by converting contingent resources - probable reserves - proven reserves - producing reserves (cash flow).

Whitecap’s Boundary Lake property is mainly in northeast British Columbia on the Alberta/British Columbia border, just east of Fort St. John. Its Deep Basin properties, which include Karr, Simonette, Kakwa, Elmworth and Wapiti, are southwest of Grande Prairie, Alberta. Its Weyburn property is in southeast Saskatchewan. The main reservoirs undergoing development are the Midale and Frobisher.

The Company’s Cardium producing areas in West Central Alberta are mainly in the Pembina, Garrington, Ferrier and Willesden Green areas. Regarding its Viking assets, its Lucky Hills, Whiteside, Kerrobert, and Eagle Lake areas are in West Central Saskatchewan. Whitecap’s Southwest Saskatchewan assets are concentrated west of Swift Current, Saskatchewan. They are characterized by predictable low base decline, medium crude oil (21° API) production.

Whitecap Resources, Inc. (SPGYF), closed Thursday's trading session at $2.93, up 0.687285%, on 57,668 volume with 67 trades. The average volume for the last 3 months is 92,137 and the stock's 52-week low/high is $0.004/$0.039299998.

chart

Propanc Biopharma, Inc. (PPCB)

InvestorsHub, Simply Wall St, Morningstar, Investors Hangout, TradingView, 4-Traders, Stockopedia, Stockflare, Stockwatch, Stockhouse, OTC Markets, Market Exclusive, and Street Insider reported earlier on Propanc Biopharma, Inc. (PPCB),  and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Propanc Biopharma, Inc. is a clinical stage Biopharmaceutical Company that focuses on the development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian, and colorectal cancers. The Company has developed a formulation of anti-cancer compounds that exert manifold effects designed to control or prevent tumors from recurring and spreading throughout the body.  Propanc Biopharma is headquartered in Melbourne, Australia.

Propanc is developing a long-term therapy based on a pancreatic proenzyme formulation to prevent tumour recurrence and metastasis. Its lead product is PRP. This is a novel, patented, formulation comprising two proenzymes mixed in a synergetic ratio.

PRP is a solution for once daily intravenous administration of a combination of two pancreatic proenzymes, trypsinogen and chymotrypsinogen, for the treatment of pancreatic cancer. PRP is an enhanced proenzyme formulation designed to enhance the anti-cancer effects of multiple enzymes acting synergistically.

Propanc Biopharma has received Orphan Drug Designation (ODD) from the Food and Drug Administration  (FDA) for the use of PRP.  The approved indication is one of the most lethal malignancies with a median survival of 6 months and a 5-year survival rate of less than 5 percent.

The FDA granted Orphan Drug Designation status to PRP for the treatment of pancreatic cancer. After extensive laboratory research and a limited amount of human testing, Propanc Biopharma has evidence that PRP reduces cancer cell growth via promotion of cell differentiation; enhances cell adhesion and may suppress metastasis progression; and has no serious side effects and improves patient survival.

Recently, Propanc Biopharma announced that a cooperation agreement was entered into between the University of Jaén and Propanc to begin the POP1 joint drug discovery program to be co-funded by both parties. This agreement coincides with the appointment of research scientist, Mr. Aitor González, to lead the drug discovery and research activities over the next 3 to 4 years. The aim of this program is to identify and develop suitable backup compounds to Propanc’s lead product candidate, PRP. As part of the agreement, Macarena Perán, Ph.D. and Julian Kenyon, M.D. were appointed as joint supervisors, representing the University and Propanc Biopharma, respectively.

Propanc Biopharma, Inc. (PPCB), closed Thursday's trading session at $1.70, up 22.3022%, on 29,170 volume with 86 trades. The average volume for the last 3 months is 9,895 and the stock's 52-week low/high is $0.25/$0.699999988.

chart

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires, Stock Twits, Tip Ranks, YCharts, Street Insider, Proactive Investors, MarketWatch, Stockwatch, Simply Wall St, Business Wire, Seeking Alpha, Promotion Stock Secrets, Wall Street Resources, The Street, Stockhouse, Penny Stocks Forever, GuruFocus, Equity Clock, Market Screener, Barchart, and Investors Hub reported previously on Cocrystal Pharma, Inc. (COCP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company uses unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics, which are safe, effective, and convenient to administer. A biotechnology enterprise, Cocrystal Pharma is headquartered in Bothell, Washington. 

  The Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with extensive nucleoside experience. Utilizing techniques called protein cocrystallization and X-ray crystallography,  Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion. The Company has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections.

Cocrystal is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme vital to viral replication and are highly conserved between all hepatitis C genotypes. Therefore, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity. 

  In addition, the Company is developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes important for viral replication. Cocrystal has also identified a picomolar inhibitor of NS5A; another crucial viral replication protein.

Recently, Cocrystal Pharma announced that it entered into an exclusive license and collaboration agreement with Merck to discover and develop certain proprietary influenza A/B antiviral agents. With this agreement, Merck will fund research and development (R&D) for the program, including clinical development. Merck will be responsible for global commercialization of any products derived from the collaboration. Cocrystal Pharma will be paid an undisclosed upfront sum. Cocrystal is eligible to receive payments related to designated development, regulatory and sales milestones with the potential to earn up to $156 million and undisclosed royalties on product sales.

Additionally, Cocrystal Pharma also recently announced safety and preliminary efficacy data for its U.S. Phase 2a study evaluating CC-31244 for the ultra-short treatment of HCV infected individuals. CC-31244 is an investigational, oral, potent, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

The treatment was well tolerated with no study discontinuations because of adverse events. Eight of 12 subjects achieved the primary efficacy endpoint of sustained virologic response at 12 weeks after completion of treatment (SVR12). SVR12 is defined as undetectable virus in blood 12 weeks after completion of treatment and considered a virologic cure.

Cocrystal Pharma, Inc. (COCP), closed Thursday's trading session at $2.88, up 16.129%, on 3,900 volume with 48 trades. The average volume for the last 3 months is 7,625 and the stock's 52-week low/high is $7.00/$11.50.

chart

Pura Naturals, Inc. (PNAT)

Stockwatch, Clay Trader, Insider Financial, Marketwired, OTC Markets, WhaleWisdon, YCharts, Spotlight Growth, Tip Ranks, Dividend Investor, and MarketWatch reported on Pura Naturals, Inc. (PNAT), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Pura Naturals, Inc. is working to deliver a purer clean by way of its innovative BeBetter Foam®. The Company is the manufacturer of unique foam cleaning products for the home. It has its proprietary foam technology, which absorbs grease and grime like a magnet. It does so without harsh chemicals and harboring of bacteria found within traditional household cleaning products and sponges. Pura Naturals is based in Lake Forest, California.

The Company focuses on plant-based products made from renewable resources with no petroleum by-products. Its product portfolio includes Health & Beauty products, including facial pads, exfoliating soap-infused body bars, soap-infused sponges, and soap-infused gentle cleansing pads for babies.

Kitchen & Household products include sponges, soap-infused sponges, non-scratch scrubbers, and non-scratch scrubbers (soap-infused). Pura Naturals’ household cleaning products deliver a unique soap infusion. The ground-breaking foam absorbs grease while repelling water and inhibiting bacteria growth and odors.

  Pura Naturals also has its Pura Naturals Marine. The specific design of its marine foam is to handle petroleum base contaminations. It is approved for use by the Environmental Protection Agency (EPA). Marine products include all-purpose sorbent Spill Pads, bilge sorbent Bilge Booms, Spill Bibs (fuel spill prevention), soap-infused personal cleaning bars, and soap-infused galley sponges.

The Pura Marine division centers on developing solutions employing AirTech Foam technologies and allied products directed towards oil spill prevention and remediation in waterways. This division is pursuing business in the trucking and oil sectors. Additionally, Pura Naturals has its all-natural cleaning solution, Pura Pro Bio-Degreaser. This product is a strong citrus based, multi-use cleaner.

Pura also has its new line of health and beauty products. These products will be infused with Cannabidiol (CBD) derived from hemp and hemp seed oils.

Recently, Pura Naturals announced that the Grease Beast products went live on HomeDepot.com. Mr. Robert Doherty, Chief Executive officer of Pura Naturals, stated on December 12, 2018, "We have been live on HomeDepot.com for only a few days, and orders are flowing. This is a solid moment for Pura Naturals. Given the talent we have brought into the Company and the breadth of the achievements thus far, we expect a very strong 2019 for the Grease Beast product line."

Pura Naturals, Inc. (PNAT), closed Thursday's trading session at $0.0025, up 18.3152%, on 3,063,825 volume with 22 trades. The average volume for the last 3 months is 845,325 and the stock's 52-week low/high is $3.5999999/$6.25.

chart

Black Cactus Global, Inc. (BLGI)

StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.

The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.

In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.

In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.

Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.

Black Cactus Global, Inc. (BLGI), closed Thursday's trading session at $0.007, up 16.6667%, on 30,868 volume with 3 trades. The average volume for the last 3 months is 31,745 and the stock's 52-week low/high is $1.75/$7.30155992.

chart

QPAGOS Corp. (QPAG)

Wallstreet Profiler, RedChip, Financial Content, Market Exclusive, ProfitableTrading, PennyDoctor, 4-Traders, Insider Tracking, Stockwatch, Marketwired, Insider Wisdom, Simply Wall St, Capital Cube, Dividend Investor, Investors Alley, Stockaholics, and Street Authority Daily reported earlier on QPAGOS Corp. (QPAG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

QPAGOS Corp. is a provider of digital payment services for cash based and unbanked consumers in Mexico. The Company operates a network of self-service kiosks and applications designed to provide more convenient payment alternatives for consumers and more efficient billing for service providers. QPAGOS has its corporate headquarters in Mexico City, Mexico. The Company lists on the OTCQB.

QPAGOS has its state-of-the-art electronic payments technology. This technology provides users with a convenient and secure alternative for paying bills, products and services, using manifold devices. These include self-service kiosks, mobile, and Personal Computer (PC)-based applications.

For service providers, QPAGOS contributes to broaden their national collections footprint. This is while reducing transactional costs. For the Company’s distributors and franchisees, QPAGOS provides a very appealing income source as they can monetize high traffic physical spaces.

For advertisers, QPAGOS provides a new channel to attract business and interact with customers. QPAGOS self-service kiosks have an integrated second screen to broadcast advertising spots and messages. For QPAGOS users, there is no more waiting in line or trying to find a remote location to make frequent payments.

QPAGOS is working to capitalize on the unbanked alternative market. It is targeting the large Latin American market with a primary emphasis on Mexico. It is doing so through the steady rollout of its user-friendly bill payment kiosks and software.

QPAGOS announced in June of 2018 year that it has partnered with Instituto del Deporte y la Recreación del Estado de Queretaro (INDEREQ), to deploy self-service kiosks and accept payments for INDEREQ members in the State of Queretaro, Mexico. INDEREQ was established as an independent public entity of the State of Queretaro. It has the mission of promoting and sponsoring sports in the State of Queretaro. Three of five initial QPAGOS self-service kiosks were installed at INDEREQ facilities.

Recently, QPAGOS announced that Q2 2018 results continued the strong revenue growth trend shown in Q1, as reported in the Company’s filed 10Q. Revenues for the three months ending June 30, 2018 were $1,701,763. This represents a 67.3 percent increase over the same quarter in 2017, and a 62.8 percent increase over the same January to June period of 2017. During Q2, collections at new locations, particularly municipalities, contributed to the growth, as QPAGOS government services solutions have expanded across the country.

QPAGOS Corp. (QPAG), closed Thursday's trading session at $0.0077, up 32.7586%, on 39,152,108 volume with 1,097 trades. The average volume for the last 3 months is 1,266,807 and the stock's 52-week low/high is $0.600000023/$2.24.

chart

NanoFlex Power Corp. (OPVS)

Dividend Investor, Zacks, Wallet Investor, Stockhouse, MarketWatch, MicroCapResearch, InvestorsHub, Super Stock Screener, and Morningstar reported earlier on NanoFlex Power Corp. (OPVS),  and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

NanoFlex Power Corp. engages in the research, development, and commercialization of advanced configuration solar technologies. These technologies enable innovative thin-film solar cell implementations. The Company believes these will be industry-leading efficiencies, light weight, flexible, and low total system cost. Listed on the OTC Markets Group’s OTCQB, NanoFlex Power has its corporate office in Scottsdale, Arizona.

The Company’s sponsored research agreements provide it with the exclusive worldwide license and right to sublicense any and all Intellectual Property (IP)  resulting from the related research and development (R&D) efforts at different universities. NanoFlex Power entered into a license agreement with SolAero Technologies Corp. For the last two-plus years, the Company and SolAero have partnered to validate NanoFlex's patented, non-destructive epitaxial lift-off (ND-ELO) process and related technologies in SolAero's ultra-high efficiency solar cells.

SolAero is a global leader in high performance photovoltaics for space and terrestrial applications. SolAero is a leading manufacturer of high efficiency solar cells.

  NanoFlex Power is part of a consortium that was awarded a $6.5 million contract from the Army Research Laboratory's Army Research Office. This consortium comprises NanoFlex Power,  SolAero Technologies, the University of Michigan (UM), and the University of Wisconsin (UW).   The contract is to develop high power, flexible, and lightweight solar modules for portable power applications with more than double the power of existing flexible solar modules within the same footprint at a competitive procurement cost on a dollars per Watt basis.

Research programs have produced two solar thin film technology platforms. One is Gallium Arsenide (GaAs) thin film technology for high power applications. The other is organic photovoltaic (OPV) technology for applications requiring high quality aesthetics.

  NanoFlex Power has the exclusive worldwide rights to license, sublicense, and bring its own products to market using the aforementioned  ND-ELO technology. ND-ELO technology has the potential to reduce compound semiconductor production costs by greater than 40 percent through enabling reuse of the expensive wafer substrate.

NanoFlex Power Corp. (OPVS), closed Thursday's trading session at $0.1018, up 22.6506%, on 2,850 volume with 3 trades. The average volume for the last 3 months is 15,896 and the stock's 52-week low/high is $N/A/$N/A.

chart

GH Capital, Inc. (GHHC)

Penny Picks, OTC Markets, MarketWatch, Barchart, Stockopedia, Morningstar, and InvestorsHub reported on GH Capital, Inc. (GHHC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

GH Capital, Inc. has developed an online payment gateway (ClickDirectPay) to process online wire transfer transactions for different online merchants, chiefly in Europe. GH Capital is a FinTech holding company and offers a going public process advisory. Formed in 2014, GH Capital has its head office in Miami, Florida. The Company lists OTC Markets’ OTCQB.

GH Capital’s Financial Technology (FinTech) product is ClickDirectPay.com. Customers using ClickDirectPay can do a bank transfer fast, easily, as well as securely with their personal online banking information. Upon using ClickDirectPay, the merchant receives a real time transaction confirmation pertaining to the successful bank transfer.

GH Capital’s goal is to expand with ClickDirectPay worldwide. To meet this objective, it is working on concepts of Blockchain and Cryptocurrency processing.

Regarding the Company’s Capital Market Advisory Service, it guides and assists international companies from the U.S, Canada, Europe, and Asia to complete the whole going public process from the beginning. GH Capital’s mission is to help small and emerging growth companies to get through the complete IPO (Initial Public Offering) process without difficulties.

GH Capital is also considering acquisitions. The Company stated that 2018 could also be a year of acquiring companies from the payment industry. This could speed up the process to establish ClickDirectPay as a one stop solution for Cryptocurrency processing.

Recently, GH Capital announced that its online payment service subsidiary, ClickDirectPay, announced the launch of ClickDirectPay's Express Coin Payments. This provides merchants the ability to accept many cryptocurrencies into a secure wallet.

In May 2018, GH Capital announced that its online payment service subsidiary, ClickDirectPay expanded its cryptocurrency payment solution offerings to support Monero, Dash, Zcash and Verge. The addition of these coins brings the total support of ClickDirectPay to 8 cryptocurrencies enabling businesses to scale their reach in accepting payments in the world of cryptocurrencies.

ClickDirectPay is introducing new tools for merchants to easily start accepting cryptocurrencies. In June, the Company announced that its online payment service subsidiary, ClickDirectPay rolled-out new tools to its online merchants to be able to more easily and quickly accept cryptocurrency as payment.

GH Capital, Inc. (GHHC), closed Thursday's trading session at $0.0037, up 48%, on 12,295,998 volume with 96 trades. The average volume for the last 3 months is 5,500,883 and the stock's 52-week low/high is $0.009999999/$1.12999999.

chart

The QualityStocks Company Corner

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) (the “Company” or “PLUS”) today announced that it has donated $60,937 to the SF LGBT Center from the sales proceeds of its annual Rainbow Sorbet limited edition gummies. As part of its commitment to strengthening and supporting communities in which it operates and sells products, PLUS contributed $1 for each of the 60,937 units of Rainbow Sorbet gummies it sold. The SF LGBT Center is committed to connecting the diverse LGBT community to opportunities, resources and each other to achieve a vision of a stronger, healthier, and more equitable world for LGBT people.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Thursday's trading session at $3.4789, up 8.7156%, on 71,260 volume with 123 trades. The average volume for the last 3 months is 49,380 and the stock's 52-week low/high is $7.00/$11.50.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in a report published by Financialnewsmedia.com. The rise of the cannabis market is being driven by consumer acceptance and demand. Consumers are not just eating cannabis up, but they are also drinking, vaping, dabbing, smoking — and the list goes on. It’s been said that consumers are calling the shots and creating the direction that the markets will go in the future. GGBXF recently announced that it expects to open its 100th Seventh Sense Botanical Therapy (“Seventh Sense”) mall-based shop on Thursday, August 8th. The first Seventh Sense shop opened in early February.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Thursday's trading session at $1.61, up 4.5455%, on 387,086 volume with 481 trades. The average volume for the last 3 months is 421,682 and the stock's 52-week low/high is $3.5999999/$6.25.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) (the "Company"), a premier provider of financial news and education for the Chinese-speaking community today announced that its Board of Directors has appointed Shelby Chan as an Independent Director, effective August 1, 2019, completing the Company's Board as its fifth member.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Thursday's trading session at $0.375, up 0.536193%, on 10,000 volume with 11 trades. The average volume for the last 3 months is 44,209 and the stock's 52-week low/high is $0.600000023/$2.24.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Global developer and provider of cellular communications systems Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a $300,000 contract to supply software to various enterprise customers through a leading cellular operator. To view the full press release, visit: http://nnw.fm/VxQe9.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Thursday's trading session at $0.3496, up 1.3333%, on 117,650 volume with 26 trades. The average volume for the last 3 months is 57,120 and the stock's 52-week low/high is $0.160099998/$0.920000016.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Leading telecommunications engineering and infrastructure services provider Spectrum Global Solutions Inc. (OTCQB: SGSI) is trusted worldwide to engineer, upgrade, install and maintain next-generation telecommunications networks. SGSI’s customers include some of the largest and most respected firms in the high-growth telecom industry, which is forecast to grow to nearly $1.5 trillion in value by 2020, according to Statista (http://nnw.fm/cU2dR).

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Thursday's trading session at $0.055, up 4.7619%, on 13,877 volume with 5 trades. The average volume for the last 3 months is 125,489 and the stock's 52-week low/high is $0.006095/$0.358999997.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) announced today that it has signed a master distribution agreement with Pure Products LLC to become the primary sales and marketing solution for the company’s line of “Pure Hemp” cigarettes. Also today, NetworkNewsWire released a report on the company detailing how CEO Greg Lambrecht joined Donald Baillargeon on MoneyTV (http://nnw.fm/V9tm3) to continue an interview regarding the company’s recent acquisition of Direct Solar. During its first 30 days with SING, Direct Solar brought in $1.7 million in contracts; that same showing was repeated during the next 30 days. SING and Direct Solar anticipate a continuation of this performance, which equates to a path to $5 million by year end. Furthermore, the company was highlighted in a publication from Investorideas.com, examining the master distribution agreement with Pure Products in greater detail.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Thursday's trading session at $0.013975, up 1.6364%, on 3,810,084 volume with 122 trades. The average volume for the last 3 months is 125,489 and the stock's 52-week low/high is $0.032000001/$2.5999999.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) today announced the virtual launch party of its premium cannabis delivery service, VivaBuds, which will initially deliver to the San Fernando Valley, located in Los Angeles, California. Also today, NetworkNewsWire released a report on the company detailing how MCOA has been flexing its muscle in the cannabis and hemp industries during recent months by building inroads to California’s world-leading market while also expanding into the international arena. The company is developing a diversified income base that provides a measure of security to shareholders while increasing its presence in a fledgling space that has exploded to such a degree that the industry is expected to hold a $66.3 billion global capitalization by 2025, growing at a CAGR of 23.9 percent, according to Grand View Research Inc. analysis (http://nnw.fm/Vw4u3). Furthermore, the company was featured today in the 420 with CNW by CannabisNewsWire.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Thursday's trading session at $0.0046, up 11.7047%, on 18,246,119 volume with 286 trades. The average volume for the last 3 months is 8,809,020 and the stock's 52-week low/high is $3.56999993/$16.25.

Recent News

chart

MustGrow Biologics Corp. (CSE: MGRO)

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics Corp. (CSE: MGRO) was featured today in the 420 with CNW by CannabisNewsWire. Last week, we reported that Regulate Florida, an advocacy group campaigning to put marijuana legalization on the 2020 state ballot had gathered enough valid votes to get the Supreme Court to review the language of their petition and that John Morgan, the personal injury lawyer who had bankrolled an initiative to legalize medical marijuana had declined to support the current push to legalize recreational marijuana saying that in his opinion, Florida wasn’t ready for such a shift. Now the lawyer has made a 180-degree turn and has decided to put his weight behind efforts to make adult-use marijuana legal in the state in 2020.

MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

MustGrow Biologics Corp. (CSE: MGRO), closed Thursday's trading session at $0.31, even for the day, on 4,000 volume. The average volume for the last 3 months is 84,797 and the stock's 52-week low/high is $1.51999998/$4.0999999.

Recent News

chart

INmune Bio Inc. (NASDAQ: INMB)

The QualityStocks Daily Newsletter would like to spotlight INmune Bio Inc. (NASDAQ: INMB).

INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased to announce that Edgardo (Ed) Baracchini, Ph.D., has joined the company’s board of directors.

INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.

INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.

INmune Bio's product pipeline targets three segments of concern:

  • Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
  • Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
  • Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.

INmune Bio Drug Candidates and Clinical Programs

INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.

In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").

Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.

INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.

Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.

XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.

The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.

Management

Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.

CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.

Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.

INmune Bio Inc. (OTC: INMB), closed Thursday's trading session at $7.12, off by 7.8913%, on 66,569 volume with 254 trades. The average volume for the last 3 months is 16,334 and the stock's 52-week low/high is $0.284999996/$5.94000005.

Recent News

chart

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games and toys in China, announces the issuance and sale of an additional 141,114 ordinary shares priced at $4 per share, before underwriting discounts and commissions, resulting in gross proceeds of $564,456, before underwriting discounts and commissions and offering expenses, pursuant to the exercise of the underwriter’s over-allotment option in connection with Blue Hat’s previously announced underwritten initial public offering (“IPO”).

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Thursday's trading session at $3.75, off by 1.8325%, on 25,415 volume with 118 trades. The average volume for the last 3 months is 355,811 and the stock's 52-week low/high is $0.004/$0.039299998.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV: YSS) (WKN: A2PMAX), on receiving its 12th cannabis retail licence from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Operating under the YSS™ brand name, the newly licensed store is strategically located in a high-traffic suburban area in northwest Edmonton. YSS has six operational stores located in Calgary and Red Deer, with an additional two licensed locations expected to open in Vermilion and Vegreville within the next week.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Thursday's trading session at $.002, off by 1.2346%, on 58,493 volume with 149 trades. The average volume for the last 3 months is 106,497 and the stock's 52-week low/high is $0.649999976/$5.25.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX:LXRP) (CNSX:LXX.CN), (the "Company" or "Lexaria") an innovator in drug delivery platforms, announces the successful completion of its Master Collaborative Research Agreement ("the R&D Program") with the National Research Council of Canada ("NRC") to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions using Lexaria's patented DehydraTECHTM technology.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Thursday's trading session at $0.807475, off by 2.5142%, on 48,678 volume with 00 trades. The average volume for the last 3 months is 000,000 and the stock's 52-week low/high is $0.119249999/$0.791499972.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSX.V: GYSR) was featured today in an article published by Investing News Network. The popularity of hemp-derived CBD products is a direct reflection of the growing global trend towards more plant-based health and wellness products. In 2018, the Global Wellness Institute estimated that the global wellness economy was a US$4.2 trillion market, growing 12.8 percent from 2015 to 2017. CBD-infused pet care products represent a new wave of this growing trend.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Thursday's trading session at $0.8075, off by 2.51%, on 48,678 volume with 39 trades. The average volume for the last 3 months is 78,787 and the stock's 52-week low/high is $0.008999999/$0.066100001.

Recent News

chart

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands LP (OTC: VPRB) is a technology holding company based in Fort Lauderdale, Florida, whose assets include patented, atomization-related products and technology. Marijuana industry watchers believe that the long wait for VPR Brands is showing signs of coming to an end, as legislation bodes well for those waiting to benefit from medical marijuana.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Thursday's trading session at $0.3307, off by 4.6699%, on 27,279 volume with 18 trades. The average volume for the last 3 months is 14,963 and the stock's 52-week low/high is $0.009999999/$1.12999999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.